COVID-19 is unlikely to be the last coronavirus to spill over to humans. Scientists are working to make a universal vaccine to combat future outbreaks.
Long COVID appears to be uncommon in children, analysis finds
Data reported through a smartphone app provides the first detailed description of COVID-19 in symptomatic school-aged children.
Pfizer to seek approval for a new COVID-19 booster shot
Citing concern over vaccine efficacy against emerging variants, Pfizer seeks approval for a third booster, but many are not yet convinced it is necessary.
Improving one of medicine’s greatest inventions: Vaccines
Integrating vaccines with biomaterials could help minimize the need for refrigeration and booster shots.
What are mRNA vaccines?
With a long history of development, mRNA vaccines are finally making their debut and changing the face of the COVID-19 pandemic.
Metabolic activators improve recovery time in patients with mild to moderate COVID-19
Small clinical trial has found that metabolic activators can improve recovery, liver health, and markers of inflammation in patients with COVID-19.
Why is there hype around the Novavax COVID-19 vaccine?
The protein-based vaccine has been highly anticipated, showing high efficacy against variants of concern.
Evaluating the filtering performance of facial masks
It’s well understood that any mask reduces the transmission of viral particles but some are more effective than others.
A smart microneedle patch to monitor and manage diabetes
Minimally invasive smart patches can continuously monitor glucose blood levels and administer insulin as needed.
Why are antiviral drugs for COVID-19 difficult to find?
Viruses are so varied and evolve so quickly that creating effective treatments against them becomes a daunting task.